Metabolomics and Mechanistic Approaches Reveal the Synergistic and Attenuating of Rubus chingii Hu on Tripterygium Glycoside Tablets in the Treatment of Rheumatoid Arthritis
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Cong Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kunshan Rehabilitation Hospital, Kunshan, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Tripterygium, Glycosides, Metabolomics. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Suzhou Pharmaceutical Association-Jiangsu Hengrui Medical Clinical Pharmacy Research Fund, Jiangsu Association of Chinese Medicine Research Fund-Eaglet Soaring Project, Kunshan Key Research and Development Program (Social Development).
Abstract (Originalsprache)
Tripterygium Glycoside Tablets (TGTs) are primary drugs for rheumatoid arthritis (RA) but pose a risk of nephrotoxicity. Rubus chingii Hu (RCH) may enhance kidney function. This study explores a combined RA treatment by examining RCH's chemical components and using a collagen‐induced arthritis (CIA) rat model to test TGTs with or without RCH. RCH boosted the therapeutic impact of TGTs in CIA rats, shown by decreased paw swelling, improved joint condition, and reduced serum TNF‐α, IL‐6, and IL‐1β levels. The normalization of renal markers (BUN and Scr) and oxidative stress indicators (ROS, T‐NOS, and T‐SOD) may be associated with the Nrf2/NF‐κB pathway. Metabolomics indicated that RCH may counteract nephrotoxicity by influencing the metabolism of glycine, serine, threonine, tryptophan, histidine, taurine, and sulfaurine. In summary, RCH synergizes with TGTs to treat RA by inhibiting inflammation, affecting metabolic pathways, reducing oxidative stress, and minimizing kidney toxicity, offering a new treatment strategy for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kunshan Rehabilitation Hospital, Kunshan, China.
- Traditional Chinese Medicine Hospital of Kunshan, Kunshan, China.
ORCID-Profile: Lei Zhang
Förderung
- Suzhou Pharmaceutical Association-Jiangsu Hengrui Medical Clinical Pharmacy Research Fund
- Jiangsu Association of Chinese Medicine Research Fund-Eaglet Soaring Project
- Kunshan Key Research and Development Program (Social Development)
Zitieren
APA
Zhang, C., Zhang, Z., Yan, F., & Zhang, L. (2026). Metabolomics and Mechanistic Approaches Reveal the Synergistic and Attenuating of Rubus chingii Hu on Tripterygium Glycoside Tablets in the Treatment of Rheumatoid Arthritis. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71696
Vancouver
Zhang C, Zhang Z, Yan F, Zhang L. Metabolomics and Mechanistic Approaches Reveal the Synergistic and Attenuating of Rubus chingii Hu on Tripterygium Glycoside Tablets in the Treatment of Rheumatoid Arthritis. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71696
BibTeX
@article{Zhang2026,
author = {Zhang, Cong and Zhang, Zepeng and Yan, Fang and Zhang, Lei},
title = {Metabolomics and Mechanistic Approaches Reveal the Synergistic and Attenuating of Rubus chingii Hu on Tripterygium Glycoside Tablets in the Treatment of Rheumatoid Arthritis},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71696}
}
EUVIMED